Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
Cash flows from operating activities:
Net income	$ 300,788	$ 240,516
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed assets	104,222	87,820
Amortization of intangibles	21,942	22,939
Amortization of deferred financing fees	2,826	3,025
Unrealized loss on foreign currency, net	18,089	7,178
(Gain) loss on disposal of fixed assets	(842)	241
Provision for doubtful accounts	1,575	(15)
Provision for sales returns	51,747	58,812
Gain on derivatives, net	(9,954)	(3,847)
Excess tax benefits from equity-based compensation plans	(46,170)	(9,563)
Deferred income taxes	(80)	2,901
Deferred compensation and stock compensation	15,882	15,214
Other	(196)	449
Changes in assets and liabilities:
Receivables	(20,697)	(9,827)
Inventories	219,417	177,665
Income tax receivable/payable, net	27,408	19,237
Other current assets	3,051	(7,861)
Other long-term assets, net	(498)	3,371
Accounts payable and accrued expenses	(83,137)	3,721
Other current liabilities	(9,133)	(137)
Other long-term liabilities	(2,620)	(7,154)
Net cash provided by operating activities	593,620	604,685
Cash flows from investing activities:
Change in restricted cash	128	3,013
Capital expenditures for fixed assets	(118,978)	(148,349)
Purchase of long-term investment	(10,000)
Other investing activities	1,207	231
Net cash used in investing activities	(127,643)	(145,105)
Cash flows from financing activities:
Net change in revolving line of credit		(184,949)
Proceeds from sale of common stock	1,243,028
Proceeds from issuance of common stock under compensation plans	26,441	9,334
Repurchase of common stock	(880,816)	(125,681)
Excess tax benefits from equity-based compensation plans	46,170	9,563
Payments on capital lease and financing obligations	(954)	(1,547)
Repayment of long-term debt	(6,517)	(3,391)
Dividends paid	(37,220)
Other financing activities	(180)	(549)
Net cash provided by (used in) financing activities	389,952	(297,220)
Effect of exchange rate changes on cash and cash equivalents	(3,866)	521
Net increase in cash and cash equivalents	852,063	162,881
Cash and cash equivalents at beginning of period	260,092	58,289
Cash and cash equivalents at end of period	1,112,155	221,170
Supplemental disclosures of cash flow information:
Fixed asset purchases included in accounts payable and not disbursed at the end of each period	43,431	21,437
Dividends declared not paid at the end of each period	40,483
Noncash investing and financing activities:
Fixed assets acquired under capital lease and financing obligations	25,390	11,769
Settlement of acquisition related liabilities through release of restricted cash		$ 9,227